Confounding effects of metformin on the human gut microbiome in Type 2 diabetes
Artikel i vetenskaplig tidskrift, 2016

Type 2 diabetes (T2D) is associated with dysbiosis of the gut microbiota, though diabetes treatment regimens, including metformin, may confound the results. Forslund et al. (2015) identify distinct disease and drug signatures and highlight the importance of adjusting for treatment when investigating how T2D influences the human gut microbiome.

Författare

Adil Mardinoglu

Chalmers, Biologi och bioteknik, Systembiologi

Jan Borén

Göteborgs universitet

Ulf Smith

Göteborgs universitet

Cell Metabolism

1550-4131 (ISSN)

Vol. 23 1 10-12

Ämneskategorier

Cell- och molekylärbiologi

DOI

10.1016/j.cmet.2015.12.012

Mer information

Skapat

2017-10-08